欢迎访问《日用化学工业(中英文)》,今天是

日用化学工业(中英文) ›› 2026, Vol. 56 ›› Issue (10): 1403-1412.doi: 10.3969/j.issn.2097-2806.2026.10.013

• 分析与检测 • 上一篇    下一篇

皮肤致敏替代方法kDPRA的联合验证研究

耿雪1,刘萍2,王开济3,陈宁4,宋艳芹5,祝清芬1,*()   

  1. 1 山东省食品药品检验研究院 国家药品监督管理局化妆品原料质量控制重点实验室, 山东 济南 250101
    2 上海市食品药品检验研究院, 上海 200233
    3 浙江省食品药品检验研究院, 浙江 杭州 310052
    4 深圳市药品检验研究院, 广东 深圳 518057
    5 烟台市食品药品检验检测中心, 山东 烟台 264035
  • 收稿日期:2025-12-01 修回日期:2026-09-10 出版日期:2026-10-22 发布日期:2026-10-30
  • 基金资助:
    国家重点研发计划“基础科研条件与重大科学仪器设备研发”专项(2022YFF0711105)

Establishment and inter-laboratory validation of the kDPRA method for skin sensitization assessment

Xue Geng1,Ping Liu2,Kaiji Wang3,Ning Chen4,Yanqin Song5,Qingfen Zhu1,*()   

  1. 1 NMPA Key Laboratory for Quality Control of Cosmetics Raw Material, Shandong Institute for Food and Drug Control, Jinan, Shandong 250101, China
    2 Shanghai Institute for Food and Drug Control, Shanghai 200233, China
    3 Zhejiang Institute for Food and Drug Control, Hangzhou, Zhejiang 310052, China
    4 Shenzhen Institute for Drug Control, Shenzhen, Guangdong 518057, China
    5 Yantai Center for Food and Drug Control, Yantai, Shandong 264035, China
  • Received:2025-12-01 Revised:2026-09-10 Online:2026-10-22 Published:2026-10-30
  • Contact: E-mail: zhuqingfen73@163.com

摘要:

研究旨在验证2022年经济合作与发展组织(OECD)发布的皮肤致敏性替代方法-动力学直接多肽反应试验(kDPRA)在我国实验室的适用性,通过考察关键试剂对结果的影响,结合实验室内部验证及四家外部实验室联合开展研究。结果显示:不同厂家单溴二胺试剂对试验结果无显著影响;市售与自制中性磷酸盐缓冲液在配方一致时对结果亦无影响;实验室内部对10种参考验证物质的致敏性分级准确率达到100%,与OECD TG 442C要求完全一致;5家实验室对10个盲样的预测准确率、灵敏度与特异度均处于80%至100%之间,符合验证要求;此外,kDPRA在组合策略中应用于黄色化合物小檗碱的致敏性评价表现良好。结果表明,kDPRA方法在我国实验室具有较好的重现性与可靠性,适宜在国内建立并转化,可作为基于有害结局路径(AOP)的皮肤致敏性组合评价策略的组成部分,为我国kDPRA方法标准的制订、推广以及动物实验替代方法体系的完善提供了科学依据与实践支持。

关键词: 致敏, 皮肤变态反应, 动力学直接多肽反应试验, OECD TG 442C, 小檗碱

Abstract:

This study systematically investigates the applicability of the kinetic direct peptide reactivity assay (kDPRA), an alternative method for skin sensitization assessment adopted by the Organisation for Economic Cooperation and Development (OECD) in 2022, in domestic laboratories. By examining the influence of key experimental factors such as reagents, the research combines internal laboratory validation with a ring test involving four external laboratories. The results show that different brands of monobromobimane reagent have no significant impact on the assay results, and commercially available versus laboratory-prepared neutral phosphate buffers yield consistent results under identical formulations. Inter-laboratory validation achieves 100% accuracy in the sensitization potency classification of 10 reference substances, fully aligning with OECD TG 442C requirements. For the 10 blind-coded samples, the predictive accuracy across the five participating laboratories ranges between 80% and 100%, meeting the validation acceptance criteria. Furthermore, kDPRA demonstrates reliable performance when applied within a defined approach for evaluating the sensitization potential of the yellow-colored compound berberine. These findings indicate that the kDPRA method exhibits good reproducibility and reliability in Chinese laboratories. It is suitable for domestic implementation and adoption, and can serve as a component of an Adverse Outcome Pathway (AOP) -based integrated testing strategy for skin sensitization assessment. This work provides scientific evidence and practical support for establishing national kDPRA standards, promoting the method, and improving China’s alternative testing system for animal experimentation.

Key words: sensitization, allergic contact dermatitis, kinetic direct peptide reactivity assay, OECD TG442C, berberine

中图分类号: 

  • TQ658